Articles with "mibc patients" as a keyword



Photo by ospanali from unsplash

Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based chemotherapy in muscle-invasive bladder cancer (MIBC) patients

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz249.030

Abstract: Abstract Background Neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care in MIBC patients, although a limited survival benefit has been obtained compared with cystectomy alone. Pathologic response has been associated with survival,… read more here.

Keywords: mibc patients; rna expression; response; signature ... See more keywords
Photo by jonasvincentbe from unsplash

Staging FDG-PET/CT for muscle-invasive bladder cancer: A nationwide population-based study.

Sign Up to like & get
recommendations!
Published in 2023 at "BJU international"

DOI: 10.1111/bju.16091

Abstract: OBJECTIVE To provide insight into the use and staging information on lymph-node involvement added by fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) provides in MIBC patients, based on a nationwide population-based cohort study. PATIENTS AND METHODS We… read more here.

Keywords: staging fdg; mibc patients; pet; patients underwent ... See more keywords

Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Oncology"

DOI: 10.1155/2022/7306198

Abstract: Background Although radical cystectomy (RC) is the clinical practice guideline-recommended treatment of muscle-invasive bladder cancer (MIBC), bladder-sparing trimodality therapy (TMT) has emerged as a valid treatment option. Findings comparing the survival outcomes for MIBC patients… read more here.

Keywords: mibc patients; bladder; radical cystectomy; patients underwent ... See more keywords
Photo by nci from unsplash

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?

Sign Up to like & get
recommendations!
Published in 2019 at "Translational Cancer Research"

DOI: 10.21037/tcr.2019.01.05

Abstract: Transl Cancer Res 2019;8(Suppl 2):S176-S179 tcr.amegroups.com Perioperative cisplatin-based combination chemotherapy is a first-line treatment strategy for muscle-invasive bladder cancer (MIBC) patients with or without metastasis. According to current European Association of Urology (EAU) guidelines, the… read more here.

Keywords: cancer; mibc patients; cisplatin; bladder cancer ... See more keywords